+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-01-27Number of Pages: 98

Oxygen Therapy Devices Market (Product Type - Oxygen Source Equipment & Oxygen Delivery Devices; Applications - Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

 
Oxygen therapy has emerged to be one of the most potential options used for treating various respiratory diseases due to its definitive, supplementary or palliative role. The administration of supplemental oxygen has become an essential element for appropriate management of a number of disease conditions. Various benefits of oxygen therapy include increased mental stamina, improved breathing pattern, and prevention of heart failure in people with severe respiratory diseases. The growing application area of oxygen therapy across various disease conditions such as chronic obstructive pulmonary disease (COPD), asthma, obstructive sleep apnea, and respiratory distress syndrome is driving the growth of the global oxygen therapy devices market. Furthermore, long-term oxygen therapy in patients with chronic lung disease is believed to improve the quality and length of life, contributing towards the growth of oxygen therapy devices market.
 
The oxygen therapy devices market is segmented by product type into oxygen source equipment and oxygen delivery devices. Oxygen source equipment is further sub-segmented into oxygen cylinders, oxygen concentrators and liquid oxygen devices. Oxygen concentrators accounted for the largest market share of the overall oxygen therapy devices market in 2013. However, liquid oxygen devices are expected to grow at the highest CAGR during the forecast period through 2014 to 2020. Factors that have contributed towards the high growth of the liquid oxygen devices are greater mobility of the device for users and their increasing application for the treatment of various respiratory disorders. Additionally, better storage capacity of liquid oxygen devices as compared to other oxygen source equipment is also expected to drive the growth of the segment. 
 
Similarly, the oxygen delivery devices market is further sub-segmented into simple oxygen masks, nasal cannula, Venturi masks, non-rebreather masks, bag valve masks and CPAP (continuous positive airway pressure) masks. Venturi masks are estimated to grow at higher CAGR. Factors such as delivery of supplemental oxygen at a precise and fixed concentration with minimum discomfort are driving the growth of the segment. Furthermore, based on applications, the oxygen therapy devices market is segmented into chronic obstructive pulmonary disease (COPD), asthma, respiratory distress syndrome, obstructive sleep apnea, pneumonia and cystic fibrosis. The COPD segment held the largest market share in 2013 of the total oxygen therapy devices market. The segment is also expected to maintain its lead during the forecast period through 2014 to 2020. Factors that accentuated the growth of the segment are high prevalence of COPD across the globe and growing patient preference to opt for oxygen therapy as their first treatment option, thereby propelling the growth of the application of oxygen therapy in COPD treatment. 
 
Geographically, North America constituted the largest market share for the global oxygen therapy devices market in 2013. Factors that have augmented the growth of the oxygen therapy devices market in North America are increasing prevalence of life-threatening respiratory diseases and better healthcare infrastructures. Furthermore, technological developments in the field of medical devices and increasing awareness of population regarding oxygen therapy are also boosting the growth of the oxygen therapy devices market in North America. According to an article published in the National Institute of Health, oxygen therapy is believed to increase the life span of individuals affected with COPD to great extent. However, Asia Pacific is predicted to foresee the highest growth rate over the forecast period. The rationale behind such high growth has been attributed to availability of large population base, greater than ever initiatives taken by the government to promote healthcare and robust economic growth. Moreover, improving consumer awareness regarding heath issues and better disease management would also drive the growth of the oxygen therapy devices market in the next few years. 
 
At present, the global oxygen therapy devices market is consolidated in nature due to the involvement of few top organizations in this field. Many emerging medical device companies are expected to foresee great development pertaining to the oxygen therapy devices market. Some of the top companies operating in the oxygen therapy devices market are Respironics, Inc. (a Philips company), Fisher & Paykel Healthcare Limited, Teleflex Incorporated, Invacare Corporation, AirSep Corporation, CareFusion Corporation, DeVilbiss Healthcare, MAQUET Holding B.V. & Co. KG, and ResMed, Inc. 
 
 

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Oxygen Therapy Devices Market
      2.1.1 Comparative Analysis: Global Oxygen Therapy Devices Market Revenue, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Global Oxygen Therapy Devices Market Overview
3.1 Introduction
3.2 Market Drivers
      3.2.1 Rise in Incidence of COPD and Other Respiratory Diseases to Provide an Impetus for Growth
      3.2.2 Increasing Patient Preference for Portable Home Oxygen Therapy Equipment Likely to Propel Market Growth
      3.2.3 Technological Advancement in the Field of Respiratory Care to Spur Market Growth
3.3 Market Restraints
      3.3.1 Poor Reimbursement Scenario and Regulatory Challenges Associated with Oxygen Therapy Devices Likely to Hamper Growth
3.4 Market Opportunities
      3.4.1 Emerging Economies to Offer Sustained Growth Opportunities
      3.4.2 Increasing Government Initiatives Toward Improving Respiratory Care
3.5 Porter’s Five Forces Analysis: Global Oxygen Therapy Devices Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of Substitutes
      3.5.4 Threat of New Entrants
      3.5.5 Competitive Rivalry
3.6 Regulatory Framework
3.7 Value Chain Analysis: Global Oxygen Therapy Devices Market
3.8 Market Attractiveness Analysis: Global Oxygen Therapy Devices Market, by Geography
 
Chapter 4 Global Oxygen Therapy Devices Market, by Product Type
4.1 Overview
      4.1.1 Global Oxygen Therapy Devices Market Revenue, by Product Type, 2012 – 2020 (USD Million)
4.2 Oxygen Source Equipment
      4.2.1 Global Oxygen Therapy Devices Market Revenue, by Oxygen Source Equipment Type, 2012 – 2020 (USD Million)
      4.2.2 Comparative Analysis: Global Oxygen Therapy Devices Market Revenue, by Oxygen Source Equipment Type, 2013 & 2020 (Value %)
      4.2.3 Oxygen Cylinders
              4.2.3.1 Global Oxygen Cylinders Market Revenue, 2012 – 2020 (USD Million)
      4.2.4 Oxygen Concentrators
              4.2.4.1 Global Oxygen Concentrators Market Revenue, 2012 – 2020 (USD Million)
      4.2.5 Liquid Oxygen Devices
              4.2.5.1 Global Liquid Oxygen Devices Market Revenue, 2012 – 2020 (USD Million)
4.3 Oxygen Delivery Devices
      4.3.1 Global Oxygen Therapy Devices Market Revenue, by Oxygen Delivery Devices Type, 2012 – 2020 (USD Million)
      4.3.2 Comparative Analysis: Global Oxygen Therapy Devices Market Revenue, by Oxygen Delivery Devices Type, 2013 & 2020 (Value %)
      4.3.3 Simple Oxygen Mask
              4.3.3.1 Global Simple Oxygen Masks Market Revenue, 2012 – 2020 (USD Million)
      4.3.4 Venturi Mask
              4.3.4.1 Global Venturi Masks Market Revenue, 2012 – 2020 (USD Million)
      4.3.5 Nasal Cannula
              4.3.5.1 Global Nasal Cannula Market Revenue, 2012 – 2020 (USD Million)
      4.3.6 Non-rebreather Mask
              4.3.6.1 Global Non-rebreather Masks Market Revenue, 2012 – 2020 (USD Million)
      4.3.7 Bag Valve Mask
              4.3.7.1 Global Bag Valve Mask Market Revenue, 2012 – 2020 (USD Million)
      4.3.8 CPAP Mask
              4.3.8.1 Global CPAP Masks Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 5 Global Oxygen Therapy Devices Market, by Application
5.1 Overview
      5.1.1 Global Oxygen Therapy Devices Market Revenue, by Application, 2012 – 2020 (USD Million)
      5.1.2 Comparative Analysis: Global Oxygen Therapy Devices Market Revenue, by Application, 2013 & 2020 (Value %)
5.2 COPD
      5.2.1 Global Oxygen Therapy Devices Market Revenue in COPD, 2012 – 2020 (USD Million)
5.3 Asthma
      5.3.1 Global Oxygen Therapy Devices Market Revenue in Asthma, 2012 – 2020 (USD Million)
5.4 Obstructive Sleep Apnea
      5.4.1 Global Oxygen Therapy Devices Market Revenue in Obstructive Sleep Apnea, 2012 – 2020 (USD Million)
5.5 Respiratory Distress Syndrome
      5.5.1 Global Oxygen Therapy Devices Market Revenue in Respiratory Distress Syndrome, 2012 – 2020 (USD Million)
5.6 Cystic Fibrosis
      5.6.1 Global Oxygen Therapy Devices Market Revenue in Cystic Fibrosis, 2012 – 2020 (USD Million)
5.7 Pneumonia
      5.7.1 Global Oxygen Therapy Devices Market Revenue in Pneumonia, 2012 – 2020 (USD Million)
 
Chapter 6 Global Oxygen Therapy Devices Market, by Geography
6.1 Overview
      6.1.1 Global Oxygen Therapy Devices Market Revenue, by Geography, 2012 – 2020 (USD Million)
6.2 North America
      6.2.1 North America Oxygen Therapy Devices Market Revenue, 2012 - 2020 (USD Million)
6.3 Europe
      6.3.1 Europe Oxygen Therapy Devices Market Revenue, 2012 - 2020 (USD Million)
6.4 Asia Pacific
      6.4.1 Asia Pacific Oxygen Therapy Devices Market Revenue, 2012 - 2020 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 RoW Oxygen Therapy Devices Market Revenue, 2012 - 2020 (USD Million)
 
Chapter 7 Recommendations
7.1 Innovation through Extensive Research and Development (R&D) Activities
7.2 Focus on Emerging Economies
7.3 Business Expansion through Inorganic Route
 
Chapter 8 Company Profiles
8.1 AirSep Corporation
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Business Strategies
      8.1.4 Recent Developments
8.2 CareFusion Corporation
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 DeVilbiss Healthcare LLC
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 Fisher and Paykel Healthcare Limited
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 Invacare Corporation
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 MAQUET Holding B.V. & Co. KG
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 ResMed
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
8.8 Philips Respironics, Inc.
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 Smiths Medical
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments
8.10 Teleflex Incorporated
      8.10.1 Company Overview
      8.10.2 Financial Overview
      8.10.3 Product Portfolio
      8.10.4 Business Strategies
      8.10.5 Recent Developments

List of Figures
 
FIG. 1 Oxygen Therapy Devices: Market Segmentation
FIG. 2 Global Oxygen Source Equipment Market, by Product Type, 2013 (USD Million)
FIG. 3 Global Oxygen Delivery Devices Market, by Product Type, 2013 (USD Million)
FIG. 4 Global Oxygen Therapy Devices Market, by Application, 2013 (USD Million)
FIG. 5 Comparative Analysis: Global Oxygen Therapy Devices Market Revenue, by Geography, 2013 & 2020 (Value %)
FIG. 6 Porter’s Five Forces Analysis: Global Oxygen Therapy Devices Market
FIG. 7 Value Chain Analysis: Global Oxygen Therapy Devices Market
FIG. 8 Market Attractiveness Analysis: Global Oxygen Therapy Devices Market, by Geography (2013)
FIG. 9 Comparative Analysis: Global Oxygen Therapy Market Revenue, by Oxygen Source Equipment Type, 2013 & 2020 (Value %)
FIG. 10 Global Oxygen Cylinders Market Revenue, 2012 – 2020 (USD Million)
FIG. 11 Global Oxygen Concentrators Market Revenue, 2012 – 2020 (USD Million)
FIG. 12 Global Liquid Oxygen Devices Market Revenue, 2012 – 2020 (USD Million)
FIG. 13 Comparative Analysis: Global Oxygen Therapy Market Revenue, by Oxygen Delivery Devices Type, 2013 & 2020 (Value %)
FIG. 14 Global Simple Oxygen Masks Market Revenue, 2012 – 2020 (USD Million)
FIG. 15 Global Venturi Masks Market Revenue, 2012 – 2020 (USD Million)
FIG. 16 Global Nasal Cannula Market Revenue, 2012 – 2020 (USD Million)
FIG. 17 Global Non-rebreather Masks Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 Global Bag Valve Masks Market Revenue, 2012 – 2020 (USD Million)
FIG. 19 Global CPAP Masks Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 Comparative Analysis: Global Oxygen Therapy Devices Market Revenue, by Application, 2013 & 2020 (Value %)
FIG. 21 Global Oxygen Therapy Devices Market Revenue in COPD, 2012 – 2020 (USD Million)
FIG. 22 Global Oxygen Therapy Devices Market Revenue in Asthma, 2012 – 2020 (USD Million)
FIG. 23 Global Oxygen Therapy Devices Market Revenue in Obstructive Sleep Apnea, 2012 – 2020 (USD Million)
FIG. 24 Global Oxygen Therapy Devices Market Revenue in Respiratory Distress Syndrome, 2012 – 2020 (USD Million)
FIG. 25 Global Oxygen Therapy Devices Market Revenue in Cystic Fibrosis, 2012 – 2020 (USD Million)
FIG. 26 Global Oxygen Therapy Devices Market Revenue in Pneumonia, 2012 – 2020 (USD Million)
FIG. 27 North America Oxygen Therapy Devices Market Revenue, 2012 – 2020 (USD Million)
FIG. 28 Europe  Oxygen Therapy Devices Market Revenue, 2012 – 2020 (USD Million)
FIG. 29 Asia Pacific Oxygen Therapy Devices Market Revenue, 2012 – 2020 (USD Million)
FIG. 30 RoW Oxygen Therapy Devices Market Revenue, 2012 – 2020 (USD Million)
FIG. 31 AirSep Corporation: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 32 CareFusion Corporation: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 33 Fisher & Paykel Healthcare Limited: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 34 Invacare Corporation: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 35 MAQUET Holding B.V. & Co. KG: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 36 ResMed: Annual Revenues, 2011 - 2013 (USD Million)
FIG. 37 Phillips Healthcare: Annual Revenue, 2011 - 2013 (USD Million)
FIG. 38 Smiths Medical: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 39 Teleflex Incorporated: Annual Revenue, 2011 – 2013 (USD Million)

List of Tables
 
TABLE 1 Market Snapshot: Global Oxygen Therapy Devices Market
TABLE 2 Global Oxygen Therapy Devices Market Revenue, by Product Type, 2012 – 2020 (USD Million)
TABLE 3 Global Oxygen Therapy Devices Market Revenue, by Oxygen Source Equipment Type, 2012 – 2020 (USD Million)
TABLE 4 Global Oxygen Therapy Devices Market Revenue, by Oxygen Delivery Devices Type, 2012 – 2020 (USD Million)
TABLE 5 Global Oxygen Therapy Devices Market Revenue, by Application, 2012 – 2020 (USD Million)
TABLE 6 Global Oxygen Therapy Devices Market Revenue, by Geography, 2012 – 2020 (USD Million)

Description: 

Oxygen therapy is a treatment that provides extra oxygen to lungs whenever a disease or respiratory condition is preventing them from getting enough oxygen. It is gaining popularity as one of the most reliable options used for the treatment of numerous types of respiratory diseases due to its supplementary, palliative, and definitive role. The administration of supplemental oxygen has become imperative for accurate management of various diseases. According to the National Institute of Health, oxygen therapy can potentially enhance the quality and length of life of individuals affected with chronic obstructive pulmonary diseases (COPD). Some of the benefits of this therapy are improved breathing pattern, increased mental stamina, and reduced risks of heart failure in people with severe respiratory disorders. The rising awareness regarding its benefits is fuelling the growth of the global oxygen therapy devices market. 

The report serves as a repository of analysis and information regarding various aspects of the global oxygen therapy devices market including value chain analysis, market dynamics, geographical segmentation, and competitive landscape. Historical data and current market scenario have been taken into account to derive the future trends anticipated in the market. 

Overview of the Global Oxygen Therapy Devices Market 

The increasing adoption of oxygen therapies as a treatment for various diseases including asthma, COPD, obstructive sleep apnea, and respiratory distress syndrome is driving the global oxygen therapy devices market. However, the shortage of proper reimbursement policies and presence of stringent regulations associated with oxygen therapy devices are likely to impede the growth of the market. 

The valuation of the global oxygen therapy devices market was US$1.9 bn in 2013 and is anticipated to rise to US$2.8 bn by 2020, expanding at a CAGR of 5.70% between 2014 and 2020. Geographically, North America was the leading market in terms of revenue in 2013. The growth of this region can be attributed to factors such as rising prevalence of life-threatening respiratory disorders, technological developments in the field of medical devices, increasing awareness regarding the benefits of oxygen therapy, and the presence of well-developed healthcare infrastructure. However, due to the presence of a large population, robust economic growth, and increasing government initiatives to promote healthcare, Asia Pacific is expected to exhibit a significant CAGR over the forecast period. 

On the basis of applications, the market is segmented into asthma, cystic fibrosis, chronic obstructive pulmonary disease, pneumonia, obstructive sleep apnea, and respiratory distress syndrome. The COPD segment will continue to dominate the market until 2020 owing to the increasing incidence of COPD across the globe and rising patient preference for oxygen therapy as their first treatment option. 

On the basis of product type, the market is categorized into two major segments: oxygen delivery devices and oxygen source equipment. The oxygen delivery devices segment is further segmented into bag valve masks, nasal cannula, CPAP masks, non-rebreather masks, and venturi masks. Out of these, venturi masks will dominate the market throughout the forecast period. The sub-segments of oxygen source equipment are liquid oxygen devices, oxygen concentrators, and oxygen cylinders. The liquid devices segment is estimated to rise at a noteworthy CAGR during the same period owing to the increasing need for improved storage capacity and greater mobility and its growing adoption for the treatment of various respiratory diseases. 

Companies Mentioned in the Global Oxygen Therapy Devices Market 

Some of the key players operating in the market are AirSep Corporation, CareFusion Corporation, Fisher & Paykel Healthcare Limited, DeVilbiss Healthcare, Invacare Corporation, MAQUET Holding B.V. & Co. KG, ResMed Inc., Respironics, Inc. (a Philips company), and Teleflex Incorporated. 

The global oxygen therapy devices market is segmented as follows: 

Oxygen Therapy Devices Market, by Product Type

  • Oxygen Source Equipment
    • Oxygen Cylinders
    • Oxygen Concentrators
    • Liquid Oxygen Devices
  • Oxygen Delivery Devices
    • Simple Oxygen Mask
    • Nasal Cannula
    • Venturi Mask
    • Non-rebreather Mask
    • Bag Valve mask
    • CPAP Mask

Oxygen Therapy Devices Market, by Applications

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma 
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome (RDS)
  • Cystic Fibrosis
  • Pneumonia

Oxygen Therapy Devices Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW) 

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 


 
 
Back To Top